Rates of spontaneous reporting of adverse drug reactions in France
Bégaud, B.; Martin, K.; Haramburu, Fçoise.; Moore, N.
JAMA 288(13): 1588
2002
ISSN/ISBN: 0098-7484 PMID: 12350188 Document Number: 547807
Document emailed within 1 workday
Related Documents
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Roeser, H.P.; Rohan, A.P. 1990: Post-marketing surveillance of drugs. The spontaneous reporting scheme: role of the Adverse Drug Reactions Advisory Committee Medical Journal of Australia 153(11-12): 720-726
Soletsky, L.M. 1997: Reporting of adverse drug reactions Postgraduate Medicine 102(1): 35-36
Kimelblatt, B.J.; Young, S.H.; Heywood, P.M.; Mandala, A.R.; Gendelman, S.; Mehl, B. 1988: Improved reporting of adverse drug reactions American Journal of Hospital Pharmacy 45(5): 1086-1089
Venulet, J. 1992: Establishing requirements for the use of terms for reporting adverse drug reactions International Journal of Clinical Pharmacology Research 12(2): 61-64
Schetz, D.; Sein Anand, J. 2015: Physician attitudes toward the reporting of adverse drug reactions on the Pomeranian region Przeglad Lekarski 72(9): 475-478
Kalaiselvan, V.; Prasad, T.; Bisht, A.; Singh, S.; Singh, G.Nath. 2014: Adverse drug reactions reporting culture in Pharmacovigilance Programme of India Indian Journal of Medical Research 140(4): 563-564
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Gram, L.F. 1995: Attitude and considerations of Danish physicians towards reporting of adverse drug reactions--a questionnaire study under European direction Ugeskrift for Laeger 157(12): 1692-1694
Schumock, G.T.; Thornton, J.P.; Witte, K.W. 1991: Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions American Journal of Hospital Pharmacy 48(9): 1974-1976
Sui, M.; Cui, L. 2017: Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach Studies in Health Technology and Informatics 245: 531-535
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Hemmingsen, B.; Støy, L.; Wetterslev, Jørn.; Tarnow, L.; Friis, K.Bach.; Christensen, L.Lundby.; Sales, N.; Gluud, C.; Madsbad, S.; Snorgaard, O.; Røder, M.; Thorsteinsson, B.; Gade-Rasmussen, B.; Jarløv, A.; Sneppen, S.; Duun, E.; Jensen, T.; Mathiesen, E.; Perrild, H.; Krarup, T.; Vestergaard, H.; Nielsen, F.; Hedetoft, C.; Breum, L.; Christensen, L.Lundby.; Lund, Søren.S.; Boesgaard, T.W.; Tarnow, L.; Pedersen, O.; Vaag, A.; Almdal, T.; Hemmingsen, B.; Wetterslev, Jørn.; Gluud, C.; Hansen, B.Visbøll.; Rosenfeldt, M.; Salas, N. 2010: Reporting adverse reactions and events in randomised clinical trials Ugeskrift for Laeger 172(35): 2381-2384
Bailie, G.R.; Verhoef, J-Jaap. 2012: Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and population Clinical Advances in Hematology and Oncology: H&o 10(2): 101-108
Bernstein, J.A. 1995: Nonimmunologic adverse drug reactions. how to recognize and categorize some common reactions Postgraduate Medicine 98(1): 120-122; 125-126
Thomas, R.E.; Lorenzetti, D.L.; Spragins, W.; Jackson, D.; Williamson, T. 2011: Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review Current Drug Safety 6(3): 145-154
Kaplan, A.S. 1984: Adverse drug reaction reporting and the family physician Journal of Family Practice 19(4): 563-564
Nelson, R.W.; Shane, R. 1983: Developing an adverse drug reaction reporting program American Journal of Hospital Pharmacy 40(3): 445-446